FDA's Initial IND Warnings For CBD Supplements Could Ignite Regulatory Test

FDA's warnings that supplements containing cannabis-derived ingredients are adulterated comes 10 months year after it stated the policy and a year after submitting other warnings that stopped short of saying the ingredients are noncompliant.